INVL Technology UTIB (VSE:INC1L)

Market Cap	43.64M
Revenue (ttm)	n/a
Net Income (ttm)	7.73M
Shares Out	11.99M
EPS (ttm)	0.64
PE Ratio	5.65
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	74
Average Volume	421
Open	3.660
Previous Close	3.640
Day's Range	3.640 - 3.660
52-Week Range	2.640 - 4.000
Beta	0.37
RSI	55.84
Earnings Date	Aug 26, 2025

About Theseus Pharmaceuticals

INVL Technology UTIB is a private equity firm specializes in later stage, mature and buyout investments. The firm primarily invests in IT industry with a focus on business climate improvement and e-governance, IT services, IT infrastructure, GovTech and FinTech, software development, and cyber security. The firm typically invests in Africa/Middle East, South-East Asia, Europe, Caribbean, Central America & Mexico. The firm prefers to invest between EUR 0.5 million ($0.53 million) to EUR 5 million ($5.32 million) in equity per transaction with an...

• Industry: Computer Programming, Data Processing, And Other Computer Related Services
• Founded: 2015
• Employees: 9
• Stock Exchange: Nasdaq Vilnius
• Ticker Symbol: INC1L